PROCESSA PHARMACEUTICALS INC (PCSA)
US74275C3043 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to PCSA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 81.6. This target is 3695.35% above the current price.
PCSA was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PCSA.
In the last month the buy percentage rose by 37 points. So the trust of analysts is improving.
PCSA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-25 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-06 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-11-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-04-04 | Benchmark | Maintains | Speculative Buy |
| 2023-04-03 | Oppenheimer | Maintains | Outperform |
| 2023-01-12 | Maxim Group | Maintains | Buy |
| 2022-04-19 | Maxim Group | Initiate | Buy |
| 2021-08-03 | Oppenheimer | Initiate | Outperform |
| 2021-08-02 | Oppenheimer | Initiate | Outperform |